Molecular Biology of liver cancer
| dc.citation.epage | 333 | en_US |
| dc.citation.spage | 323 | en_US |
| dc.contributor.author | Öztürk, Mehmet | en_US |
| dc.contributor.author | Çetin-Atalay, Rengül | en_US |
| dc.contributor.editor | Meyers, R. A. | |
| dc.date.accessioned | 2019-05-21T07:05:38Z | |
| dc.date.available | 2019-05-21T07:05:38Z | |
| dc.date.issued | 2005 | en_US |
| dc.department | Department of Molecular Biology and Genetics | en_US |
| dc.description.abstract | Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related mortality worldwide. Recent advances in the molecular profiling of HCC emphasize its intratumoral heterogeneity and reveal how cellular pathways are altered in favor of tumor progression. Malignant transformation of primary liver cancer is achieved through the acquisition of cancer hallmark capabilities that promote the uncontrolled proliferation of hepatocytes. In this review, the characteristics and acquired capabilities of human primary liver cancer, based on the HCC-specific genetic and epigenetic alterations, are described and discussed. Keywords: HBV A small DNA virus that infects hepatocytes in the liver, causing acute or chronic hepatitis; HCV A small RNA virus that infects hepatocytes in the liver, causing acute or chronic hepatitis; genome-wide expression; gene signatures; PI3K/AKT pathway; MAPK/ERK pathway; p53 ; hTERT | en_US |
| dc.identifier.isbn | 9783527305438 | |
| dc.identifier.uri | http://hdl.handle.net/11693/51442 | |
| dc.language.iso | English | en_US |
| dc.publisher | Wiley-Blackwell Publishing | en_US |
| dc.relation.ispartof | Encyclopedia of molecular cell Biology and molecular medicine | en_US |
| dc.title | Molecular Biology of liver cancer | en_US |
| dc.type | Book Chapter | en_US |